Comparison between saralsin and converting enzyme inhibitor in hypertensive disease.
D000804:Angiotensin II / Q000037:antagonists & inhibitors / Q000378:metabolism; D000806:Angiotensin-Converting Enzyme Inhibitors; D001794:Blood Pressure / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000503:physiopathology*; D006978:Hypertension, Renovascular / Q000503:physiopathology; D009842:Oligopeptides / Q000494:pharmacology*; D012083:Renin / Q000097:blood; D012504:Saralasin; D012964:Sodium / Q000172:deficiency / Q000378:metabolism; D013722:Teprotide / Q000494:pharmacology*
D000806:Angiotensin-Converting Enzyme Inhibitors; D009842:Oligopeptides; D000804:Angiotensin II; D012964:Sodium; D013722:Teprotide; D012083:Renin; D012504:Saralasin